These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 16845110)

  • 1. FAF-Drugs: free ADME/tox filtering of compound collections.
    Miteva MA; Violas S; Montes M; Gomez D; Tuffery P; Villoutreix BO
    Nucleic Acids Res; 2006 Jul; 34(Web Server issue):W738-44. PubMed ID: 16845110
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FAF-Drugs2: free ADME/tox filtering tool to assist drug discovery and chemical biology projects.
    Lagorce D; Sperandio O; Galons H; Miteva MA; Villoutreix BO
    BMC Bioinformatics; 2008 Sep; 9():396. PubMed ID: 18816385
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FAF-Drugs3: a web server for compound property calculation and chemical library design.
    Lagorce D; Sperandio O; Baell JB; Miteva MA; Villoutreix BO
    Nucleic Acids Res; 2015 Jul; 43(W1):W200-7. PubMed ID: 25883137
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The FAF-Drugs2 server: a multistep engine to prepare electronic chemical compound collections.
    Lagorce D; Maupetit J; Baell J; Sperandio O; Tufféry P; Miteva MA; Galons H; Villoutreix BO
    Bioinformatics; 2011 Jul; 27(14):2018-20. PubMed ID: 21636592
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FAF-Drugs4: free ADME-tox filtering computations for chemical biology and early stages drug discovery.
    Lagorce D; Bouslama L; Becot J; Miteva MA; Villoutreix BO
    Bioinformatics; 2017 Nov; 33(22):3658-3660. PubMed ID: 28961788
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Frog: a FRee Online druG 3D conformation generator.
    Leite TB; Gomes D; Miteva MA; Chomilier J; Villoutreix BO; Tufféry P
    Nucleic Acids Res; 2007 Jul; 35(Web Server issue):W568-72. PubMed ID: 17485475
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In silico ADME-Tox modeling: progress and prospects.
    Alqahtani S
    Expert Opin Drug Metab Toxicol; 2017 Nov; 13(11):1147-1158. PubMed ID: 28988506
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    Ekins S; Lane TR; Urbina F; Puhl AC
    Xenobiotica; 2024 Jul; 54(7):352-358. PubMed ID: 37539466
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Free Web-Based Protocol to Assist Structure-Based Virtual Screening Experiments.
    Lagarde N; Goldwaser E; Pencheva T; Jereva D; Pajeva I; Rey J; Tuffery P; Villoutreix BO; Miteva MA
    Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31546814
    [TBL] [Abstract][Full Text] [Related]  

  • 10. e-LEA3D: a computational-aided drug design web server.
    Douguet D
    Nucleic Acids Res; 2010 Jul; 38(Web Server issue):W615-21. PubMed ID: 20444867
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Implementation of an ADME enabling selection and visualization tool for drug discovery.
    Stoner CL; Gifford E; Stankovic C; Lepsy CS; Brodfuehrer J; Prasad JV; Surendran N
    J Pharm Sci; 2004 May; 93(5):1131-41. PubMed ID: 15067690
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Applying machine learning techniques for ADME-Tox prediction: a review.
    Maltarollo VG; Gertrudes JC; Oliveira PR; Honorio KM
    Expert Opin Drug Metab Toxicol; 2015 Feb; 11(2):259-71. PubMed ID: 25440524
    [TBL] [Abstract][Full Text] [Related]  

  • 13. e-Drug3D: 3D structure collections dedicated to drug repurposing and fragment-based drug design.
    Pihan E; Colliandre L; Guichou JF; Douguet D
    Bioinformatics; 2012 Jun; 28(11):1540-1. PubMed ID: 22539672
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Open Source Bayesian Models. 1. Application to ADME/Tox and Drug Discovery Datasets.
    Clark AM; Dole K; Coulon-Spektor A; McNutt A; Grass G; Freundlich JS; Reynolds RC; Ekins S
    J Chem Inf Model; 2015 Jun; 55(6):1231-45. PubMed ID: 25994950
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In Silico and Ex silico ADME approaches for drug discovery.
    Darvas F; Keseru G; Papp A; Dormán G; Urge L; Krajcsi P
    Curr Top Med Chem; 2002 Dec; 2(12):1287-304. PubMed ID: 12470281
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ADMETlab 2.0: an integrated online platform for accurate and comprehensive predictions of ADMET properties.
    Xiong G; Wu Z; Yi J; Fu L; Yang Z; Hsieh C; Yin M; Zeng X; Wu C; Lu A; Chen X; Hou T; Cao D
    Nucleic Acids Res; 2021 Jul; 49(W1):W5-W14. PubMed ID: 33893803
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improving early drug discovery through ADME modelling: an overview.
    Wishart DS
    Drugs R D; 2007; 8(6):349-62. PubMed ID: 17963426
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Precompetitive preclinical ADME/Tox data: set it free on the web to facilitate computational model building and assist drug development.
    Ekins S; Williams AJ
    Lab Chip; 2010 Jan; 10(1):13-22. PubMed ID: 20024044
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Two-dimensional (2D) in silico models for absorption, distribution, metabolism, excretion and toxicity (ADME/T) in drug discovery.
    Khakar PS
    Curr Top Med Chem; 2010; 10(1):116-26. PubMed ID: 19929825
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of ABC transporters in drug absorption, distribution, metabolism, excretion and toxicity (ADME-Tox).
    Szakács G; Váradi A; Ozvegy-Laczka C; Sarkadi B
    Drug Discov Today; 2008 May; 13(9-10):379-93. PubMed ID: 18468555
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.